Application no. and date | 17794505.2 (espacenet) (Federated) (European Patent Register), 20171019 | Patent/reg. no. and date | DK/EP 3529236, 20240207 | Publication date | 20190828 | Priority no. and date | US 201662410230 P, 20161019 | EP pub. no. and date |
EP 3529236 20190828 | Effective date | | Applicant/owner | Tetraphase Pharmaceuticals, Inc., 35 Gatehouse Drive, Suite E0
Waltham, MA 02451, US | Applicant ref. no. | 1687763 | Inventor | HOGAN, Philip, C., 437 Washington St. Apt. 1
Brighton, MA 02135, US, NIU, John, 20 Reeves Road
Bedford, MA 01730, US, HE, Minsheng, 34 Marland Street
Andover, MA 01810, US, LAFRANCE, Danny, 22A Wellesley Ave
Natick, MA 01760, US, LIU, Yansheng, 8 Ginn Road
Winchester, MA 01890, US, CHEN, Chi-Li, 11 Waban Street
Newton, MA 02458, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/65 (2006.01) , A61P 1/00 (2006.01) , A61P 1/02 (2006.01) , A61P 13/02 (2006.01) , A61P 31/00 (2006.01) , A61P 31/04 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , C07D 295/15 (2006.01) | Title | KRYSTALFORMER AF ERAVACYCLIN | Int. application no. | US2017057385 | Int. publication no. | WO2018075767 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|